Form 8-K - Current report:
SEC Accession No. 0001193125-25-146179
Filing Date
2025-06-25
Accepted
2025-06-25 08:05:35
Documents
14
Period of Report
2025-06-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d917821d8k.htm   iXBRL 8-K 26042
2 EX-99.1 d917821dex991.htm EX-99.1 12912
6 GRAPHIC g917821g0625032502159.jpg GRAPHIC 2866
  Complete submission text file 0001193125-25-146179.txt   158949

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qttb-20250620.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qttb-20250620_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qttb-20250620_pre.xml EX-101.PRE 10810
17 EXTRACTED XBRL INSTANCE DOCUMENT d917821d8k_htm.xml XML 3522
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 251071047
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)